{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:36:29Z","timestamp":1791070589219,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.nbd.2012.03.040","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T14:45:41Z","timestamp":1334241941000},"page":"194-200","source":"Crossref","is-referenced-by-count":82,"title":["Selective increase of two ABC drug efflux transporters at the blood\u2013spinal cord barrier suggests induced pharmacoresistance in ALS"],"prefix":"10.1016","volume":"47","author":[{"given":"Michael R.","family":"Jablonski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena A.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Maragakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Pasinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Trotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2012.03.040_bb0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.22421","article-title":"The blood\u2013spinal cord barrier: morphology and Clinical Implications","volume":"70","author":"Bartanusz","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2012.03.040_bb0010","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/jcbfm.2008.16","article-title":"Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood\u2013brain barrier","volume":"28","author":"Bauer","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2012.03.040_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boill\u00e9e","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2012.03.040_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2008.06.010","article-title":"Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis","volume":"213","author":"Boston-howes","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.040_bb0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","article-title":"Ultrastructure of blood\u2013brain barrier and blood\u2013spinal cord barrier in SOD1 mice modeling ALS","volume":"1157","author":"Garbuzova-Davis","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2012.03.040_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jneuroim.2006.05.012","article-title":"Isolation and culture of microvascular endothelial cells from murine spinal cord","volume":"177","author":"Ge","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2012.03.040_bb0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood\u2013brain barrier P-glycoprotein reduces brain A\u03b2 in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.040_bb0040","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2012.03.040_bb0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1471-4159.2003.02181.x","article-title":"An ALS mouse model with a permeable blood\u2013brain barrier benefits from systemic cyclosporine A treatment","author":"Kirkinezos","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.03.040_bb0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.040_bb0055","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1208\/aapsj070112","article-title":"Role of the breast cancer resistance protein (ABCG2) in drug transport","volume":"7","author":"Mao","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.nbd.2012.03.040_bb0060","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1073\/pnas.0308726100","article-title":"RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.040_bb0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1471-4159.2007.04772.x","article-title":"Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood\u2013brain barrier","volume":"103","author":"Milane","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.03.040_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2008.12.061","article-title":"Interactions between riluzole and ABCG2\/BCRP transporter","volume":"452","author":"Milane","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2012.03.040_bb0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2010.01.078","article-title":"P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis","volume":"472","author":"Milane","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2012.03.040_bb0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tips.2010.03.003","article-title":"Regulation of P-glycoprotein and other ABC drug transporters at the blood\u2013brain barrier","volume":"31","author":"Miller","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2012.03.040_bb0085","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/mol.58.6.1357","article-title":"Xenobiotic transport across isolated brain microvessels studied by confocal microscopy","volume":"58","author":"Miller","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.040_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2995","article-title":"Engaging neuroscience to advance translational research in brain barrier biology","volume":"12","author":"Neuwelt","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.040_bb0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","article-title":"Impaired blood\u2013brain and blood\u2013spinal cord barriers in mutant SOD1-linked ALS rat","volume":"1301","author":"Nicaise","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2012.03.040_bb0100","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1523\/JNEUROSCI.4184-10.2011","article-title":"Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G93A transgenic ALS mice","volume":"31","author":"Ozdinler","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.040_bb0105","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11095-008-9735-8","article-title":"Curcumin inhibits the activity of ABCG2\/BCRP1, a multidrug resistance-linked ABC drug transporter in mice","volume":"26","author":"Shukla","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.nbd.2012.03.040_bb0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/01.wnl.0000223353.34006.54","article-title":"Neuroprotective agents for clinical trials in ALS: a systematic assessment","volume":"67","author":"Traynor","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2012.03.040_bb0115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/mol.110.063685","article-title":"Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood\u2013brain","volume":"78","author":"Wang","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.03.040_bb0120","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","article-title":"TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration","volume":"106","author":"Wegorzewska","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.040_bb0125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nn2073","article-title":"ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration","volume":"11","author":"Zhong","year":"2008","journal-title":"Nat. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112001295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112001295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T03:57:47Z","timestamp":1713844667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996112001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0969996112001295"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2012.03.040","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}